Showing results (71-80 of 762) with videos related to
Sort By:
Pageof 77
Pharmacogenetics and Genomics|August 22, 2009
Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphismStefan Vegter, Annalisa Perna, Wâtse Hiddema, et al.Journal of the American Medical Informatics Association : JAMIA|March 6, 2009
Developing regulatory-compliant electronic case report forms for clinical trials: experience with the demand trialBogdan Ene-Iordache, Sergio Carminati, Luca Antiga, et al.Hypertension (Dallas, Tex. : 1979)|July 22, 2009
Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapyPiero Ruggenenti, Dario Cattaneo, Giacomina Loriga, et al.International Journal of Cardiology|December 5, 2018
Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: A cross-sectional and longitudinal substudy of the ALADIN trialLetizia Spinelli, Antonio Pisani, Giuseppe Giugliano, et al.Journal of the American Society of Nephrology : JASN|April 30, 2011
ACE inhibition is renoprotective among obese patients with proteinuriaFrancesca Mallamaci, Piero Ruggenenti, Annalisa Perna, et al.Journal of the American Society of Nephrology : JASN|August 20, 2011
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibitionCarmine Zoccali, Piero Ruggenenti, Annalisa Perna, et al.Data in Brief|December 12, 2018
Data on the assessment of LV mechanics by speckle tracking echocardiography in ADPKD patientsLetizia Spinelli, Antonio Pisani, Giuseppe Giugliano, et al.Nephron|December 13, 2016
Conversion from Brand-Name Neoral to the Generic Ciqorin in Stable Renal Transplant RecipientsMonica Cortinovis, Eliana Gotti, Matias Trillini, et al.Nephron|July 24, 2019
Accelerating the Depletion of Circulating Anti-Phospholipase A2 Receptor Antibodies in Patients with Severe Membranous Nephropathy: Preliminary Findings with Double Filtration Plasmapheresis and OfatumumabManuel Alfredo Podestà, Alessia Gennarini, Valentina Portalupi, et al.Circulation|February 5, 2003
Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathiesPiero Ruggenenti, Naobumi Mise, Roberto Pisoni, et al.Pageof 77